SRH Zentralklinikum Suhl GmbH
- Address
- Albert-Schweitzer-Strasse 2, 98527 Suhl, Germany
SRH Zentralklinikum Suhl GmbH - Multispecialty Clinical Research Center
SRH Zentralklinikum Suhl GmbH is a comprehensive medical research facility engaged in diverse clinical investigations spanning oncology, rare genetic disorders, and sensory medicine. The center demonstrates particular strength in advanced therapeutic trials, including enzyme replacement therapies and novel drug delivery systems.
- Advanced breast cancer research, focusing on HER2-negative, hormone receptor positive disease with novel targeted therapies and antibody-drug conjugates
- Rare metabolic disorders including Late Metachromatic Leukodystrophy (MLD) with intrathecal enzyme replacement therapy
- Otologic disorders and innovative treatment approaches for Idiopathic Sudden Sensorineural Hearing Loss
The research center's oncology program is particularly robust, conducting trials evaluating progression-free survival and invasive disease-free survival outcomes in patients with high-risk breast cancer. In the realm of rare diseases, the facility participates in long-term safety extension studies for enzyme replacement therapies, demonstrating commitment to follow-up care and comprehensive patient monitoring. Additionally, the center explores alternative therapeutic delivery methods, including comparative studies of intratympanic versus oral steroid administration for acute auditory conditions.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 10 by active trials.
No sponsors linked to active trials.
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
No repeated partnerships found.
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 2 161 other sites in Germany
Therapeutic Area Benchmark — Germany
Select a therapeutic area to compare against other sites in Germany.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Germany
Market Share
Country: Germany
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in SRH Zentralklinikum Suhl GmbH
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Evaluation of Intratympanic AC102 Versus Oral Prednisolone in Idiopathic Sudden Sensorineural Hearing Loss: A Randomized, Blinded, Phase II Study | AudioCure Pharma GmbH | Phase II | Not Recruiting | Aug 2022 | Jan 2026 |
IMP list
lock Showing 1 of 7 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| 6-Fluoro-9-Methyl-9H-Pyrido[3,4-B]-Indole | 1 | Unknown | 2022-08-08 | 2022-08-08 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.